Amarin Corporation PLC (AMRN) vs Nasus Pharma Ltd. (NSRX)
Amarin Corporation PLC and Nasus Pharma Ltd. are both Drug Manufacturers General companies. Amarin Corporation PLC is the larger, with a market value of $283.6M against $40.8M — 7.0× the size. Across the 8 metrics below, Nasus Pharma Ltd. leads on 5 and Amarin Corporation PLC on 3.
Valuation
Profitability
| Metric | AMRN | NSRX | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 41.96% | — | 72.77% |
| Operating margin | (21.89%) | — | 18.90% |
| Net margin | (14.56%) | — | 8.27% |
| Free cash flow margin | 8.36% | 0.00% | 17.25% |
| Return on equity | (5.97%) | 0.00% | 6.97% |
| Return on assets | (4.19%) | 0.00% | 2.76% |
| Return on invested capital | (19.79%) | 0.00% | 6.30% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack